Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and tolerability of multiple escalating doses of BMS-663513 when given in combination with paclitaxel and carboplatin.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06927297 · Advanced Solid Tumor Malignancies, Advanced Solid Malignancies
NCT02934568 · Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
NCT06760481 · Advanced Solid Malignancies
NCT04521413 · Advanced Solid Malignancies
NCT06388902 · Advanced Solid Malignancies
University Of Pennsylvania Medical Center
Philadelphia, Pennsylvania
Magee-Womens Hospital Of Upmc
Pittsburgh, Pennsylvania
University Of Virginia
Charlottesville, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions